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No reduction in mortality after centralisation 
in treatment of patients with ruptured 
abdominal aneurism
Ruptured abdominal aortic aneurism (rAAA) is a severe 
condition with all-cause mortality rates reaching 80% 
[1]. Roughly two thirds of patients with rAAA reach the 
hospital and 40% of these die before surgery [1]. The 
incidence of rAAA in Denmark is 83/1,000,000, corre-
sponding to 400 to 520 new annual cases [2]. The 30-
day mortality rate in Denmark has remained stable 
around 30-40% in the past two decades [2].
In 2008, the treatment of patients with rAAA in 
Denmark was centralised and today six, instead of ten, 
national centres treat patients with rAAA [3]. Central-
isation has been demonstrated to improve outcomes in 
rAAA treated with endovascular repair and in other 
acute surgical conditions, such as ruptured suprarenal 
aneurisms and aortic dissections [4, 5]. We hypothe-
sised that this would also be the case for patients sur-
gically treated for rAAA. 
Accordingly, the aim of this population-based obser-
vational study was to describe temporal trends in mor-
tality for patients undergoing surgery for rAAA in the 
Capital Region of Denmark between 2009 and 2015. 
METHODS
Study design and approvals
This was a population-based retrospective cohort study 
of patients post-operatively admitted to the intensive 
care unit (ICU) following surgery for rAAA at Rigshos-
pitalet between 1 January 2009 and 31 December 
2015. We have prepared this manuscript according to 
the Strengthening the Reporting of Observational  
Studies in Epidemiology statement [6]. The study was 
approved by the Danish Data Protection Agency  
(RH-2016-391) and The Danish Health Authority (3-
3013-932/I). As the design of the study was observa-
tional, ethical approval was waived by the regional re-
search ethics committee. 
Population
We included all consecutive patients with the Interna-
tional Classification of Diseases-10 code DI71.3 (rup-
tured abdominal aortic aneurism), surgically treated 
for rAAA at Rigshospitalet. Patients who died before 
surgery or before reaching the ICU were excluded.  
Also, patients with non-ruptured AAA, ruptured thora-
coabdominal aortic aneurisms or iliacal aneurisms 
were not included. No other exclusion criteria were  
applied. 
Organisation of treatment of ruptured  
abdominal aortic aneurism in Denmark
Since 2008, vascular surgery in Denmark has been cen-
tralised at seven hospitals, and six of these provide 
acute surgery to patients with rAAA. At Rigshospitalet 
40-50 patients undergo surgery for rAAA annually, rep-
resenting approximately a third of the total number of 
rAAA procedures performed in Denmark [3, 7]. The 
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hospital covers an area of 10,000 square kilometres 
with approximately 2.7 million inhabitants [8]. Post-
operatively, all patients are transferred to the ICU for 
post-operative management, irrespective of risk factors 
or post-operative physiological state. All patients 
treated for rAAA in the study period were managed by 
open surgical repair with insertion of a vascular pros-
thesis [7].
Data extraction and variables
Patients were identified through the Critical Informa-
tion System, an electronic patient data-managing sys-
tem used in the ICU. Patients were cross-checked with 
the surgery-planning programme ORBIT, the Danish 
Vascular Registry and the medical files. 
We extracted the following demographic, baseline 
and in-hospital data: gender, age, BMI, smoking status, 
treatment with oral anticoagulants, comorbidities (dia-
betes mellitus, hypertension, ischaemic heart disease, 
chronic obstructive pulmonary disease, cerebrovascu-
lar disease and renal failure), intraoperative blood loss, 
blood transfusion during surgery, duration of surgery, 
the Sequential Organ Failure Assessment score [9], and 
the Simplified Acute Physiology Score II [10]. From the 
Danish National Patient Registry [8], we retrieved data 
on mortality. 
Outcome measures
The primary outcome measure was death within 90 
days of the primary surgical procedure. Secondary out-
comes measures were: 1) death within 30 days of the 
primary surgical procedure, 2) death within one year of 
the primary surgical procedure, 3) secondary surgery as-
sociated with the primary surgical procedure before dis-
charge from hospital,4) intestinal ischaemia ir re spect ive 
of whether this was surgically verified or a tentative di-
agnosis, 5) renal replacement therapy during the ICU 
stay, 6) sepsis [11] and 7) length of stay in the ICU. 
Statistical analyses
Baseline and clinical characteristics are presented as 
medians with interquartile ranges (IQR) for continuous 
variables, and frequencies and percentages for categor-
ical variables, stratified for 90-day mortality. We com-
pared survivors and non-survivors using the chi-
squared test or Fisher’s exact test for categorical 
variables, and Student’s t-test or the Wilcoxon rank-
sum test for continuous variables, as appropriate. The 
prevalence of missing data is presented in Table 1.  
All statistical tests were two-tailed, and a p < 0.05 was 
considered statistically significant. The survival prob-
abilities were estimated using the Kaplan-Meier 
method. We used SAS software 9.4 for the analyses.
Trial registration: not relevant.
RESULTS
A total of 339 patients were diagnosed with rAAA and 
scheduled for surgery at Rigshospitalet from January 
2009 to December 2015. Nine patients were cancelled 
before reaching the operating theatre because add-
itional treatment was considered futile, and 55 patients 
(16.7%) died in the theatre due to excessive bleeding 
or other complications. In total, 275 patients were in-
cluded in the final study population (Figure 1). 
The number of patients surgically treated annually 
for rAAA fell in the 35-45 range (Figure 2A). The ma-
jority of patients were males (86.6%), the median 
(IQR) age was 73 years (68-77), and most of the pa-
tients had one or more comorbidities (Table 1). In gen-
eral, survivors were younger, had a lower disease se-
verity, fewer co-existing diseases and experienced 
fewer complications (Table 1 and Table 2). 
A total of 26.9% (74/275) of the patients died 
within 90 days of the primary surgical procedure, 
whereas the 30-day and one-year mortality was 18.5% 
and 31.6%, respectively (Figure 2A). No consistent re-
duction in mortality was observed throughout the ob-
servation period, although the 90-day mortality rate 
varied between 20% and 38% (Figure 2A). The long-
term survival is presented in Figure 2B. The figure illus-
trates a high mortality rate in the first six months fol-
lowing surgery, after which the curve flattens out. 
Around 50%of the patients remained alive seven years 
after their rAAA.
A total of 88 patients (32%) underwent re-surgery, 
36 patients (13.1%) developed intestinal ischaemia 
and 59 patients (21.5%) required renal replacement 
therapy due to acute kidney injury. In total, 150 pa-
tients (54.6%) suffered one or more post-operative 
complications (Table 2), and the median (IQR) length 
of stay in the ICU was 4.3 days (1.7-7.7days). 
DISCUSSION
In this retrospective population-based cohort study of 
275 patients admitted to the ICU following open sur-
gical repair for rAAA at Rigshospitalet from 2009 to 
2015, we found a high morbidity and mortality with no 
consistent reduction in mortality following centralisa-
tion. In contrast to the findings in studies of other sur-
gical conditions [4, 5, 12, 13], we observed no consist-
ent reduction in mortality following centralisation of 
the treatment in 2008. This is somewhat surprising as 
open surgical repair of rAAA is a complicated surgical 
procedure in which the anaesthetic and surgical team 
needs routine, which they are assumed to achieve with 
centralisation. Perhaps there are too few cases per year 
to gain significant experience in handling these critic-
ally ill patients. In ovarian cancer and oesofago-gastric 
cancer, centralisation resulted in improved outcomes 
[12, 13]. The reason for this is likely the higher volume 
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of patients at each centre, yielding more experience in 
the multidisciplinary handling of these patients and a 
higher quality of care. Although nearly one third of  
patients with rAAA in Denmark are treated at Rigs-
hospitalet the surgical volume may be too low – as 
compared to other surgical conditions – to improve the 
quality of care and outcome. It may is also possible that 
the number is high enough to make further centralisa-
tion irrelevant. 
In the process of centralisation of the treatment of 
patients with rAAA, the surgeons might have been re-
allocated to a new department along with the proced-
ure, so that the number of procedures performed by 
each surgeon remained unchanged. This was the case 
in a British study from 2018 [14], and  might, at least 
partly, explain the observed lack of an improved out-
come following the centralisation of surgery for rAAA 
in Denmark  as well. This is supported by the fact that 
the number of procedures performed at Rigshospitalet 
annually, has not increased significantly after the cen-
tralisation (Figure 2A). 
Another explanation for the lack of an improved 
outcome following centralisation may be that the bene-
TABLE 1
Baseline and demographic characteristics of patients undergoing open repair for ruptured abdominal aortic aneurism at Rigshospitalet in 2009-2015. Stratified by 
90-day mortality. 
Non-survivors Survivors Total Patients with missing  
values n (%)(nn = 201) (ns = 74) (N = 275) p-value
Age, median (IQR), yrs 71 (67-76) 76 (71-80) 73 (68-77) < 0.01   0 (0.0)
BMI, median (IQR), kg/m2 26.1 (23.8-29.4) 26.1 (24.3-28.1) 26.1 (23.8-29.3) 0.40   3 (1.1)
Male gender, n (%) 174 (86.6) 64 (86.5) 238 (86.6) 0.99   0 (0.0)
SAPSII, median (IQR) 40 (35-48) 51 (42-63) 43 (36-52) < 0.1 27 (9.8)
Co-existing diseases, n (%)
COPD   30 (15.9) 22 (32.8)   52 (20.3) 0.01 19 (6.9)
Ischaemic heart disease   55 (27.6) 21 (29.2)   76 (26.6) 0.80   4 (1.5)
Hypertension 129 (64.8) 44 (62.0) 173 (64.1) 0.67   5 (1.8)
Cerebrovascular disease   32 (16.2) 20 (27.8)   52 (19.3) 0.03   5 (1.8)
Renal failure   11 (5.5)   6 (8.3)   17 (6.3) 0.40a   4 (1.5)
Current smoker   87 (53.1) 20 (39.2) 107 (49.8) 0.20 60 (21.8)
Diabetes   29 (14.5)   9 (12.5)   38 (14.0) 0.67   3 (1.1)
Pre-operative medications, n (%)
Betablocker 45 (24.5) 12 (19.4) 57 (23.2) 0.41 29 (10.5)
Clopidogrel, n (%) 10 (5.3)   4 (6.2) 14 (5.5) 0.76a 20 (7.3)
Acetylsalicylic acid, n (%) 79 (41.6) 20 (32.3) 99 (39.3) 0.19 23 (8.4)
Warfarin, n (%) 14 (7.3) 11 (16.9) 25 (9.7) 0.02 18 (6.5)
Intra-operative variables
Duration of surgery, median (IQR), min. 179 (144-228) 187 (142-262) 180 (144-237) 0.21b   0 (0.0)
Estimated blood loss, median (IQR), l 5.1 (3.3-7.3) 6.6 (3.8-10.9) 5.5 (3.4-8.1) 0.02b   7 (2.5)
Red cell transfusion, median (IQR), l 3.2 (2.2-4.2) 4.4 (2.5-5.9) 3.4 (2.2-5.0) < 0.01b 11 (4.0)
COPD = chronically obstructive lung disease; IQR = interquartile range; SAPS = Simplified Acute Physiology Score.
a) Fisher’s exact test. 
b) Wilcoxon rank-sum test.
FIGURE 1
Patient flow diagram of patients diagnosed and planned for  
surgery at Rigshospitalet between 2009 and 2015.
Patients diagnosed with rAAA and  
planned for surgery at Rigshospitalet 
from 2009 to 2015 (N = 339)
Patients deemed unfit for surgery  
(n = 9)
Patients who died in theatre  
due to uncontrolled bleeding  
or other complications (n = 55)
Patients reaching the operating theatre 
(n = 330)
Patients admitted alive to the ICU 
after open repair for rAAA (n = 275)
ICU = intensive care unit; rAAA = ruptured abdominal aortic aneurism.
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fits from centralisation need more time to take effect 
[15]. Also, patients with rAAA are severely ill with a 
high risk of an adverse outcome, why the impact of 
central isation on the outcome may be difficult to detect 
(low absolute effect). Finally, it may be that we did not 
detect a reduction in mortality because we did not reg-
ister data before the centralisation; only after the cen-
tralisation. Compared with an earlier cohort from the 
same centre [16], mortality was lower. In general, the 
outcome at Rigshospitalet is at the same level as in 
other European centres [17, 18]. The strengths of our 
study include its population-based design with a low 
risk of selection bias, a high data completeness and a 
high data validity [19].
A number of limitations also apply. First, the single-
centre design may limit generalisability to other centres 
with a different case mix. Second, our cohort did not 
include patients treated with endovascular aortic re-
pair. Third, patients who died before and during sur-
gery were not accounted for; this will tend to under-
estimate the reported mortality. Most other cohorts 
include these cases, which need to be considered when 
comparing outcomes. Fourth, the number of patients 
treated outside the Capital Region of Denmark before 
and after the centralisation remains unknown; this may 
have affected the temporal trends observed. Fifth, the 
observational design with retrospective data collection 
is prone to selection bias and confounding, including 
residual confounding and confounding by indication. 
Sixth, the statistical power is low due to the limited 
number of included patients. Finally, we did not use 
statistical process control to assess the temporal time 
trends, as recently recommended [20].
CONCLUSIONS
In this retrospective population-based cohort study of 
275 patients admitted to the ICU following open sur-
gical repair for rAAA at Rigshospitalet between 2009 
and 2015, we found an overall high morbidity and 
mortality with no consistent reduction in mortality over 
time following centralisation. 
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TABLE 2
Secondary outcomes stratified by survival 90 days after repair for ruptured abdominal aortic 
aneurism at Rigshospitalet in 2009-2015. Stratified by 90-day mortality. 
Survivors Non-survivors Total
(ns = 201) (nn = 74) (N = 275) p-value
Post-operative renal replacement therapy, 
n (%)
32 (15.9) 27 (36.5) 59 (21.4) < 0.01
Re-operative surgery, n (%) 52 (25.9) 36 (48.7) 88 (32.0) < 0.01
Bowel ischaemia, n (%) 16 (8.0) 20 (27.0) 36 (13.1) < 0.01
Septic shock, n (%) 17 (8.5) 26 (35.1) 43 (15.6) < 0.01
Length of stay in ICU, median (IQR), days 4.1 (1.7-7.9) 5.2 (1.7-11.0) 4.3 (1.7-9.4) 0.28a
ICU = intensive care unit; IQR = interquartile range.
a) Wilcoxon rank-sum test.
FIGURE 2
A. Number of patients admitted to the intensive care unit after 
surgery for ruptured abdominal aortic aneurism at Rigshospitalet 
per year and the post-operative mortality in the 2009-2015 period. 
B. Overall survival of patients treated for ruptured abdominal aor-
tic aneurism at Rigshospitalet in the period 2009-2015 period. 
The shaded area shows the 95% confidence interval.
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